Quantum Capital Management (California)’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | – | Sell |
-5,885
| Closed | -$501K | – | 154 |
|
2018
Q4 | $501K | Sell |
5,885
-37,157
| -86% | -$3.16M | 0.29% | 87 |
|
2018
Q3 | $4.17M | Sell |
43,042
-2,853
| -6% | -$277K | 1.49% | 9 |
|
2018
Q2 | $4.32M | Sell |
45,895
-80,974
| -64% | -$7.63M | 1.66% | 4 |
|
2018
Q1 | $10.3M | Buy |
126,869
+17,171
| +16% | +$1.39M | 2.48% | 5 |
|
2017
Q4 | $9.78M | Buy |
109,698
+14,461
| +15% | +$1.29M | 2.34% | 6 |
|
2017
Q3 | $8.86M | Sell |
95,237
-11,533
| -11% | -$1.07M | 2.09% | 11 |
|
2017
Q2 | $9.7M | Sell |
106,770
-13
| -0% | -$1.18K | 2.39% | 9 |
|
2017
Q1 | $9.37M | Buy |
106,783
+12,995
| +14% | +$1.14M | 2.33% | 9 |
|
2016
Q4 | $7.77M | Buy |
93,788
+25,270
| +37% | +$2.09M | 2.09% | 13 |
|
2016
Q3 | $6.34M | Sell |
68,518
-96,996
| -59% | -$8.97M | 1.77% | 22 |
|
2016
Q2 | $12.9M | Sell |
165,514
-7,292
| -4% | -$567K | 1.82% | 29 |
|
2016
Q1 | $14.3M | Buy |
172,806
+85,476
| +98% | +$7.05M | 1.93% | 24 |
|
2015
Q4 | $9.15M | Buy |
+87,330
| New | +$9.15M | 1.19% | 38 |
|
2015
Q2 | – | Sell |
-84,145
| Closed | -$6.07M | – | 163 |
|
2015
Q1 | $6.07M | Buy |
84,145
+2,224
| +3% | +$160K | 1.33% | 35 |
|
2014
Q4 | $7.41M | Sell |
81,921
-8,400
| -9% | -$759K | 1.69% | 25 |
|
2014
Q3 | $6.52M | Sell |
90,321
-6,995
| -7% | -$505K | 1.28% | 31 |
|
2014
Q2 | $6.05M | Sell |
97,316
-12,521
| -11% | -$779K | 1.03% | 39 |
|
2014
Q1 | $7.49M | Sell |
109,837
-52,144
| -32% | -$3.56M | 1.22% | 33 |
|
2013
Q4 | $11.4M | Buy |
161,981
+36,844
| +29% | +$2.59M | 1.93% | 5 |
|
2013
Q3 | $9.03M | Sell |
125,137
-12,491
| -9% | -$901K | 1.78% | 8 |
|
2013
Q2 | $7.67M | Buy |
+137,628
| New | +$7.67M | 1.56% | 21 |
|